A Randomized, Controlled Study of DTaP-IPV-HB-PRP-T, a Fully Liquid Hexavalent Vaccine, Administered in a 3, 5 and 11-12 Month Schedule.

Timo Vesikari, Sven Arne Silfverdal, Emilia Jordanov, Emmanuel Feroldi

Research output: Contribution to journal › Article › Scientific › peer-review

24 Citations (Scopus)

Original language	English
Journal	The Pediatric Infectious Disease Journal
DOIs	https://doi.org/10.1097/INF.0000000000001358
Publication status	Published - 2016
Publication type	A1 Journal article-refereed

Publication forum classification

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{0e6effd078624c60ba732640fb871955,

title = "A Randomized, Controlled Study of DTaP-IPV-HB-PRP-T, a Fully Liquid Hexavalent Vaccine, Administered in a 3, 5 and 11-12 Month Schedule.",

author = "Timo Vesikari and Silfverdal, {Sven Arne} and Emilia Jordanov and Emmanuel Feroldi",

year = "2016",

doi = "10.1097/INF.0000000000001358",

language = "English",

}

TY - JOUR

T1 - A Randomized, Controlled Study of DTaP-IPV-HB-PRP-T, a Fully Liquid Hexavalent Vaccine, Administered in a 3, 5 and 11-12 Month Schedule.

AU - Vesikari, Timo

AU - Silfverdal, Sven Arne

AU - Jordanov, Emilia

AU - Feroldi, Emmanuel

PY - 2016

Y1 - 2016

U2 - 10.1097/INF.0000000000001358

DO - 10.1097/INF.0000000000001358

M3 - Article

SN - 0891-3668

JO - The Pediatric Infectious Disease Journal

JF - The Pediatric Infectious Disease Journal

ER -